![](/img/cover-not-exists.png)
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients
Mohamad A. Hussein, Laura Wood, Eric Hsi, Gordan Srkalovic, MaryAnn Karam, Paul Elson, Ronald M. BukowskiVolume:
95
Year:
2002
Language:
english
Pages:
9
DOI:
10.1002/cncr.10946
File:
PDF, 91 KB
english, 2002